CD4 and COVID-19: During recovery, survivors with severe or critical course of COVID-19 (groups B and C) had significantly increasing total number of CD3+ cells (Figure 7A) (p = 0.022) and CD3+CD4+ cells (Figure 7B) (p = 0.037), however, no statistically significant differences were found in the dynamics among other lymphocytes subsets.